相关实验视频
Updated: Jan 12, 2026

07:20
Inducement and Evaluation of a Murine Model of Experimental Myopia
Published on: January 22, 2019
10.4K
对于控制近视的阿特罗宾疗效的种族和剂量依赖差异:系统性审查和元分析
Sayantan Biswas1, Carla Lanca2, Daisy Kynman-Sprinks1
1School of Optometry, College of Health and Life Sciences, Aston University, Birmingham, UK.
The British journal of ophthalmology
|October 30, 2025
概括
形眼液有效地减缓了儿童近视的进展,较高度显示出更大的影响. 疗效因种族而异,在东亚儿童中更为明显.
科学领域:
- 眼科医生 眼科 眼科
- 临床药理学 临床药理学
背景情况:
- 临床不确定性存在于近视控制的最佳阿特罗宾度和持续时间.
- 亚洲和非亚洲儿童之间对近视控制的阿特罗宾疗效的差异需要调查.
研究的目的:
- 为了评估不同度的热素对近视控制的疗效.
- 为了比较东亚,南亚和白人欧洲儿童的近视控制结果.
主要方法:
- 34项随机对照试验 (RCT) 的系统综述和元分析,至少12个月的随访时间.
- 包括年龄小于16岁的近视儿童,接受了阿特罗宾治疗.
- 聚合的加权平均差异 (WMD) 在球体等效折射 (SER) 和轴长度 (AL) 的进展,通过氨酸度和种族.
主要成果:
- 与对照组相比,阿特罗平显著减少了所有度的近视进展.
- 较高的阿特罗宾度显示,SER和AL进展的减少更大.
- 与南亚和白人欧洲儿童相比,东亚儿童的近视控制效果显著更大.
结论:
- 阿特罗平表明,剂量依赖的近视进展在1-5年内减缓.
- 在亚洲儿童中,特别是东亚儿童中,对近视控制的阿特罗宾疗效更大.
- 在量身定制阿托治疗策略时,种族特异性考虑至关重要.
相关概念视频
Open Angle Glaucoma: Treatment
951
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
951
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.7K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.7K
Direct-Acting Cholinergic Agonists: Pharmacological Actions
2.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.2K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.8K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.8K
Cholinergic Antagonists: Pharmacokinetics
895
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
895
Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.5K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.5K

